Author

F. Nakashima

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Pozzi· 1 shared C. Schneider· 1 shared G. A. Sulikowski· 1 shared J. A. Gimenez-Bastida· 1 shared M. Chiusa· 1 shared P. B. Luis· 1 shared R. E. Boer· 1 shared S. H. Presley· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Pozzi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The 5-LOX/COX-2 cross-over metabolite, hemiketal E2, enhances VEGFR2 activation and promotes angiogenesis

F. Nakashima, J. A. Gimenez-Bastida, P. B. Luis, S. H. Presley, R. E. Boer, M. Chiusa, T. Shibata, G. A. Sulikowski, A. Pozzi, C. Schneider

This study identifies HKE2, a cross-over metabolite of 5-LOX and COX-2, as a pro-angiogenic agent that activates VEGFR2 and promotes angiogenesis in vitro and in vivo.

bioRxiv · May 13, 2022 · PreprintPharmacology & Toxicology